Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
featured
EINSTEIN CHOICE

EINSTEIN CHOICE

  • 353 views
  • 08 Nov, 2020
  • 1 location
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

support the use of intraprocedural anticoagulation to mitigate the risk of radial artery occlusion however the role of post-procedural anticoagulation has not been previously evaluated. Rivaroxaban is a

  • 11 views
  • 26 Jan, 2021
  • 1 location
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events Hospitalization and Death in Medically Ill Outpatients With Acute Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

The purpose of this study is to evaluate whether rivaroxaban reduces the risk of a composite endpoint of major venous and arterial thrombotic events, all-cause hospitalization, and all-cause

fatigue
cancer
myalgia
diabetes
nasopharyngeal swab
  • 14 views
  • 29 Aug, 2021
  • 17 locations
Study of Rivaroxaban for CeREbral Venous Thrombosis

SECRET examines the safety of rivaroxaban versus standard-of-care for treatment of symptomatic cerebral venous thrombosis, initiated within 14 days of diagnosis.

  • 1 views
  • 25 Jan, 2021
  • 13 locations
Rivaroxaban in Type 2 Myocardial Infarctions

This trial is the pilot phase of a randomized controlled trial to test the feasibility of recruiting patients with a type 2 myocardial infarction and randomizing them to low-dose rivaroxaban to

  • 0 views
  • 18 Apr, 2021
  • 1 location
WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

The trial is a pharmacodynamic study to determine the effect of a novel regimen of aspirin 20 mg BD plus rivaroxaban 2.5 mg BD on haemostasis, fibrin clot dynamics, inflammatory markers

  • 0 views
  • 21 Sep, 2021
  • 1 location
COVID-19 Antithrombotic Rivaroxaban Evaluation

adjunctive treatment in the context of COVID-19. Indeed, it will be tested the hypothesis that the use of moderate dose of rivaroxaban has a beneficial effect in the treatment of patients with a confirmed or

  • 0 views
  • 05 Sep, 2021
  • 36 locations
Rivaroxaban or Aspirin for Biological Aortic Prosthesis

recipient endothelium. There are no conclusive studies of anticoagulation and the investigators have shown stroke to be a common complication. Guidelines have variably recommended aspirin or rivaroxaban for

stroke
infarct
warfarin
rivaroxaban
blood clot
  • 0 views
  • 22 Jan, 2021
  • 3 locations
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

> Rivaroxaban, a direct coagulation factor a inhibitor, blocks the formation of the clot. ROCKET-AF study has shown that the efficacy of rivaroxaban is not inferior to that of warfarin in AF patients on stroke

stroke
anticoagulants
cerebral infarction
infarct
warfarin
  • 13 views
  • 11 Feb, 2021
  • 1 location
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by

anticoagulants
apixaban
venous thromboembolism
rivaroxaban
probe
  • 285 views
  • 29 Jan, 2021
  • 21 locations